EMMA VILLAS SPA (EAV.MI) Fundamental Analysis & Valuation

BIT:EAVIT0005562183

Current stock price

1.22 EUR
-0.02 (-1.61%)
Last:

This EAV.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. EAV.MI Profitability Analysis

1.1 Basic Checks

  • EAV had negative earnings in the past year.
  • EAV had a negative operating cash flow in the past year.
EAV.MI Yearly Net Income VS EBIT VS OCF VS FCFEAV.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 1M -1M -2M -3M

1.2 Ratios

  • With a Return On Assets value of -6.78%, EAV is not doing good in the industry: 68.66% of the companies in the same industry are doing better.
  • The Return On Equity of EAV (-29.62%) is worse than 70.15% of its industry peers.
Industry RankSector Rank
ROA -6.78%
ROE -29.62%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EAV.MI Yearly ROA, ROE, ROICEAV.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 10 -10 -20

1.3 Margins

  • EAV has a Gross Margin of 7.82%. This is in the lower half of the industry: EAV underperforms 65.67% of its industry peers.
  • The Profit Margin and Operating Margin are not available for EAV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EAV.MI Yearly Profit, Operating, Gross MarginsEAV.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 5 10 15

2

2. EAV.MI Health Analysis

2.1 Basic Checks

  • EAV does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for EAV remains at a similar level compared to 1 year ago.
  • The debt/assets ratio for EAV is higher compared to a year ago.
EAV.MI Yearly Shares OutstandingEAV.MI Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 2M 4M 6M
EAV.MI Yearly Total Debt VS Total AssetsEAV.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 5M 10M 15M

2.2 Solvency

  • EAV has an Altman-Z score of 1.78. This is a bad value and indicates that EAV is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of EAV (1.78) is better than 83.58% of its industry peers.
  • A Debt/Equity ratio of 1.10 is on the high side and indicates that EAV has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 1.10, EAV is in line with its industry, outperforming 40.30% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF N/A
Altman-Z 1.78
ROIC/WACCN/A
WACC6.45%
EAV.MI Yearly LT Debt VS Equity VS FCFEAV.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 2M -2M 4M

2.3 Liquidity

  • A Current Ratio of 0.93 indicates that EAV may have some problems paying its short term obligations.
  • With a Current ratio value of 0.93, EAV is not doing good in the industry: 61.19% of the companies in the same industry are doing better.
  • EAV has a Quick Ratio of 0.93. This is a bad value and indicates that EAV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • EAV's Quick ratio of 0.93 is fine compared to the rest of the industry. EAV outperforms 64.18% of its industry peers.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.93
EAV.MI Yearly Current Assets VS Current LiabilitesEAV.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 2M 4M 6M 8M 10M

1

3. EAV.MI Growth Analysis

3.1 Past

  • EAV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -239.43%.
  • EAV shows a small growth in Revenue. In the last year, the Revenue has grown by 3.97%.
EPS 1Y (TTM)-239.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.13%
Revenue 1Y (TTM)3.97%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%3.5%

3.2 Future

  • EAV is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -19.26% yearly.
  • EAV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.44% yearly.
EPS Next Y-100%
EPS Next 2Y-48.7%
EPS Next 3Y-19.26%
EPS Next 5YN/A
Revenue Next Year2.87%
Revenue Next 2Y3.21%
Revenue Next 3Y5.44%
Revenue Next 5YN/A

3.3 Evolution

EAV.MI Yearly Revenue VS EstimatesEAV.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
EAV.MI Yearly EPS VS EstimatesEAV.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2026 2027 0.1 0.2 0.3

0

4. EAV.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for EAV. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EAV.MI Price Earnings VS Forward Price EarningsEAV.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EAV.MI Per share dataEAV.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • A cheap valuation may be justified as EAV's earnings are expected to decrease with -19.26% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-48.7%
EPS Next 3Y-19.26%

0

5. EAV.MI Dividend Analysis

5.1 Amount

  • EAV does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

EAV.MI Fundamentals: All Metrics, Ratios and Statistics

EMMA VILLAS SPA

BIT:EAV (4/1/2026, 7:00:00 PM)

1.22

-0.02 (-1.61%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.39%
Inst Owner ChangeN/A
Ins Owners86.09%
Ins Owner ChangeN/A
Market Cap8.50M
Revenue(TTM)33.81M
Net Income(TTM)-1.31M
Analysts80
Price Target2.38 (95.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.25
P/FCF N/A
P/OCF N/A
P/B 1.93
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.19
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.57
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS4.85
BVpS0.63
TBVpS-0.53
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.78%
ROE -29.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.82%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score0
Asset Turnover1.75
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 222.84%
Cap/Sales 6.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.93
Altman-Z 1.78
F-Score0
WACC6.45%
ROIC/WACCN/A
Cap/Depr(3y)145.26%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-239.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.13%
EPS Next Y-100%
EPS Next 2Y-48.7%
EPS Next 3Y-19.26%
EPS Next 5YN/A
Revenue 1Y (TTM)3.97%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%3.5%
Revenue Next Year2.87%
Revenue Next 2Y3.21%
Revenue Next 3Y5.44%
Revenue Next 5YN/A
EBIT growth 1Y-233.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-71.51%
EBIT Next 3Y-11.23%
EBIT Next 5YN/A
FCF growth 1Y-128.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-126.69%
OCF growth 3YN/A
OCF growth 5YN/A

EMMA VILLAS SPA / EAV.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of EMMA VILLAS SPA (EAV.MI) stock?

ChartMill assigns a fundamental rating of 1 / 10 to EAV.MI.


What is the valuation status for EAV stock?

ChartMill assigns a valuation rating of 0 / 10 to EMMA VILLAS SPA (EAV.MI). This can be considered as Overvalued.


Can you provide the profitability details for EMMA VILLAS SPA?

EMMA VILLAS SPA (EAV.MI) has a profitability rating of 0 / 10.